T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference

Rhea-AI Summary

T2 Biosystems, a leader in rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced its participation in the Canaccord Genuity Annual Growth Conference in Boston on August 11, 2022, at 8:00am ET. The presentation will be accessible via a live and recorded webcast on the Company’s website. T2 Biosystems focuses on improving patient care with products like the T2Dx® Instrument and various detection panels, leveraging its proprietary T2 Magnetic Resonance technology. The company has a pipeline of future products aimed at detecting bacterial and fungal pathogens.

LEXINGTON, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming Canaccord Genuity Annual Growth Conference in Boston, Massachusetts.

Management is scheduled to present on Thursday, August 11, 2022, at 8:00am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat™ Panel, the T2Cauris™ Panel, and T2Lyme™ Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

What is T2 Biosystems participating in on August 11, 2022?

T2 Biosystems will participate in the Canaccord Genuity Annual Growth Conference in Boston.

At what time will T2 Biosystems present at the conference?

T2 Biosystems is scheduled to present at 8:00am ET on August 11, 2022.

How can I access the T2 Biosystems presentation?

The presentation can be accessed via a live and recorded webcast on T2 Biosystems' website.

What technologies does T2 Biosystems use for pathogen detection?

T2 Biosystems uses T2 Magnetic Resonance technology for the rapid detection of sepsis-causing pathogens and antibiotic resistance genes.

What products does T2 Biosystems offer?

T2 Biosystems offers products including the T2Dx® Instrument and various detection panels like T2Bacteria® and T2Candida®.